AFFLUENCE

The Exchange has sought clarification from AAVAS Financiers Ltd on April 13, 2026, with reference to news appeared in https://cfo.economictimes.indiatimes.com/dated April 13, 2026, quoting "Aavas Financiers may be headed for leadership change; Kotak's Manu Singh likely to be next CEO."The reply is awaited.

With reference to the email received from the Exchange dated 13th April 2026 seeking clarification on the movement in the price of our security at the exchangein the recent past, please find reply for the same.

Inter alia considered and transacted the following business: 01. The Board of Directors has considered and approved the proposal for incorporation of a Wholly Owned Subsidiary Company (100% ownership) at Ras Al Khaimah Economic Zone Authority, United Arab Emirates (UAE), under the name and style of M/s Aqylon Nexus Holding LLC or such other name as may be approved by the appropriate authorities. The Board has authorized Mr. Kiran Kumar Inampudi [DIN:01024343] Director, to take all necessary steps, as may be required in this connection. This strategic decision follows the overwhelming growth and strong market demand for our AI Technology Products and Services. Encouraged by this positive response and recognizing the United Arab Emirates (UAE) as the next major growth market for our products, the Company has decided to expand its international footprint through this new incorporation in United Arab Emirates (UAE). 2. Mr. Sripal Reddy Molugu [DIN: 03642466] has resigned from the post of Independent Director of Company with effect from 10th April 2026, due to pre-occupancy and other commitments. He has confirmed that there is no material reason for his resignation other than mentioned in his resignation letter. 3. The Board of Directors has acknowledged the receipt of a proposal (?the Proposal?) from M/s Energon Petroproducts Private Limited, expressing their intention to sell their entire shareholding of 33,73,690 equity shares, representing 100% of the share capital. The Board has authorized Mr. Srivatsava Sunkara [DIN: 01725431], Managing Director, to take all necessary actions as may be required in this regard.

Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement and Corrignendum to the Detailed Public Statementunder Regulation 18(7) in terms of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the Public Shareholders of the Aspira Pathlab &Diagnostics Ltd ("Target Company").

BALAXI PHARMACEUTICALS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.